Development of 89Zr-Radiolabelled Obinutuzumab: as a Potential Immuno-PET Agent

Copy For Citation

Sarcan Bozkır E. T., Paısey S., Ruthard M., Özer A. Y., Marshall C., Hartman N.

20th European Symposium on Radiopharmacy and Radiopharmaceuticals, Verona, Italy, 24 November 2022, (Summary Text)

• Publication Type: Conference Paper / Summary Text
• City: Verona
• Country: Italy
• Hacettepe University Affiliated: Yes